PureTech Health plc – Half-Year Report
BOSTON–(BUSINESS WIRE)–PureTech Health plc – Half-Year Report Source link ... Read More
Indiva Reports Second Quarter 2023 Results
LONDON, Ontario–(BUSINESS WIRE)–Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the second fiscal quarter ended June 30, 2023. All figures are reported in Canadian dollars ($), unless otherwise indicated. Indiva’s ... Read More
One80 Intermediaries Expands Transportation Practice With Acquisition of GMI Insurance
BOSTON–(BUSINESS WIRE)–One80 Intermediaries (One80), a specialty insurance broker headquartered in Boston, today announced that it has acquired GMI Insurance. Terms of the deal were not disclosed. Established in 1980, GMI Insurance (GMI) is a Pennsylvania-based Managing General Agent specializing in commercial transportation and related insurance. The company initially focused on ... Read More
Tips for Expanding Your Cannabis Business Online
People start cannabis businesses for various reasons. Some see cannabis only as a means to financial gains, while others want to break down the stigma around cannabis and connect with those in their community. If you’re among those who focus on connection, and you want to connect with even more ... Read More
Texas Original Continues Dallas-Fort Worth Expansion, Opens Plano Permanent Medical Cannabis Location
AUSTIN, Texas–(BUSINESS WIRE)–Texas Original announced the opening of a permanent medical cannabis pickup location in Plano, expanding patient access in the DFW area. Source link ... Read More
Enveric Biosciences Strengthens Intellectual Property Portfolio with New U.S. Patent for Tryptamine-derived Prodrugs
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,707,447, titled “C4-Carbonothioate-substituted Tryptamine Derivatives ... Read More